Bottom line
ABRJX vs AMCPX: the short answer
ABRJX (ABR 50/50 Volatility Fund) and AMCPX (Amcap Fund) are both mutual funds.
But AMCPX is far broader, holding 121 positions to 9 for ABRJX, so beyond the top names it adds exposure ABRJX doesn't have.
AMCPX is cheaper at 0.64% vs 2.75% — a difference of $211 a year per $10,000 invested.
Over five years, AMCPX returned +9.2% a year vs +9.0% for ABRJX (reporting dates differ).
AMCPX has a front-end sales load of up to 5.75%; the other does not.
Updated Nov 19, 2026
ABRJX vs AMCPX side by side
| ABRJX | AMCPX | |
|---|---|---|
| Type | Mutual fund | Mutual fund |
| Fund family | Forum II | American Funds (Capital Group) |
| Category | Large Blend | Large Blend |
| Expense ratio | 2.75% | 0.64% |
| Annual cost per $10k | $275 | $64 |
| 10-yr cost on $10k (prospectus) | $4,215 | $1,327 |
| Max front load | 0% | 5.75% |
| 12b-1 fee | 0.25% | 0.24% |
| 1-yr return | +13.7% | +11.0% |
| 5-yr return (annualized) | +9.0% | +9.2% |
| 10-yr return (annualized) | — | +12.0% |
| Best quarter | — | +23.2% |
| Worst quarter | — | −19.5% |
| Net assets (fund) | $28.2M | $97.2B |
| Number of holdings | 9 | 121 |
| Portfolio turnover | 1,292% | 36% |
| Returns as of | Dec 31, 2024 | Dec 31, 2025 |
Source: SEC Form N-PORT and fund prospectuses
Holdings overlap
ABRJX and AMCPX share none of their top holdings.
ABRJX top 10
- N/a — 45.25%
- US Treasury N/b — 2.59%
- US Treasury N/b — 2.59%
- US Treasury N/b — 2.59%
- US Treasury N/b — 2.59%
- US Treasury N/b — 2.56%
- US Treasury N/b — 2.56%
- N/a — -12.06%
- N/a — -18.01%
AMCPX top 10
- Broadcom Inc — 7.58%
- Nvidia Corp — 7.04%
- Amazon.com Inc — 6.21%
- Alphabet Inc — 5.77%
- Microsoft Corp — 5.63%
- Eli Lilly And Co — 4.59%
- Meta Platforms Inc — 3.84%
- Taiwan Semiconductor Manufacturing Co Ltd — 3.36%
- Transdigm Group Inc — 2.29%
- Vertex Pharmaceuticals Inc — 2.14%
FAQ
What is the difference between ABRJX and AMCPX?
Which is cheaper, ABRJX or AMCPX?
Should I own both ABRJX and AMCPX?
Educational comparison based on public filings; not investment advice. Past performance does not guarantee future results.